Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
Mycobacterium tuberculosis remains one of the world's contributors to mortality. With the emergence of SARS-CoV-2 coinfections, patients with TB are predisposed to being more heavily weighed down by COVID-19 disease and its opportunistic coinfections. The severity of the disease coupled with dr...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-07-01
|
Series: | Scientific African |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468227621001289 |
id |
doaj-9dd3b57134704c0a8c26e005f95d50fd |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andrew G. Mtewa Jonathan T. Bvunzawabaya Kennedy J. Ngwira Fanuel Lampiao Reuben Maghembe Hedmon Okella Anke weisheit Casim U. Tolo Patrick E. Ogwang Duncan C. Sesaazi |
spellingShingle |
Andrew G. Mtewa Jonathan T. Bvunzawabaya Kennedy J. Ngwira Fanuel Lampiao Reuben Maghembe Hedmon Okella Anke weisheit Casim U. Tolo Patrick E. Ogwang Duncan C. Sesaazi Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing Scientific African Ligand efficiency β-ketoacyl-ACP synthase Drug design KasA inhibitor Drug-protein interactions M. tuberculosis |
author_facet |
Andrew G. Mtewa Jonathan T. Bvunzawabaya Kennedy J. Ngwira Fanuel Lampiao Reuben Maghembe Hedmon Okella Anke weisheit Casim U. Tolo Patrick E. Ogwang Duncan C. Sesaazi |
author_sort |
Andrew G. Mtewa |
title |
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing |
title_short |
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing |
title_full |
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing |
title_fullStr |
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing |
title_full_unstemmed |
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing |
title_sort |
ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with β-ketoacyl-acp synthase (kasa) in potential anti-tubercular drug designing |
publisher |
Elsevier |
series |
Scientific African |
issn |
2468-2276 |
publishDate |
2021-07-01 |
description |
Mycobacterium tuberculosis remains one of the world's contributors to mortality. With the emergence of SARS-CoV-2 coinfections, patients with TB are predisposed to being more heavily weighed down by COVID-19 disease and its opportunistic coinfections. The severity of the disease coupled with drug resistance on the currently used drugs warrants for the search for alternative remedies from synthetic agents, semisynthetics and natural products that include plants. Africa is rich in plant diversity with a promise as sources of drug agents, one of which is Eichhornia crassipes. This work aimed at isolating a fatty acid and dock it to β-ketoacyl-ACP synthase for possible anti-TB drug development prospects using computational tools. (9z,12z)-Octadeca-9,12-dienoic acid was isolated from Eichhornia crassipes for the first time using chromatographic techniques and identified using 1D and 2D NMR spectroscopic methods (1H NMR, COSY, HSQC, HMBC and 13C NMR). The compound was then docked to β-ketoacyl-ACP synthase (KasA), an essential member of the b-ketoacyl synthases encoded in the M. tuberculosis genome in comparison with its co-crystallized ligand JSF-3285, also for the first time. (9z,12z)-Octadeca-9,12-dienoic acid interacted with only phenylalanine239 and proline201 while JSF-3285 interacted with proline201, glutamine120, alanine119, leucine116, glutamine199, histadine345, phenylalanine239, glycine240 and glycine200. (9z,12z)-Octadeca-9,12-dienoic acid had a ligand efficiency of 0.24, compared to the co-crystallized ligand's 0.36. The compound was too flexible and elongated with -4.72 KCalmol−1 binding energy. Despite some unfavourable physico-chemical properties, the compound still provides reliable interactions that only require logical structural modifications by the addition of polar regions amongst others to increase interactions and ligand efficiency, which can consequently stand to be a better potential drug lead. For the first time, plant-based (9z,12z)-Octadeca-9,12-dienoic acid isolated from Eichhornia crassipes was shown to interact fairly well with β-ketoacyl-ACP synthase and proved to be a potential starting material from which anti-tubercular drugs can be designed. |
topic |
Ligand efficiency β-ketoacyl-ACP synthase Drug design KasA inhibitor Drug-protein interactions M. tuberculosis |
url |
http://www.sciencedirect.com/science/article/pii/S2468227621001289 |
work_keys_str_mv |
AT andrewgmtewa ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning AT jonathantbvunzawabaya ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning AT kennedyjngwira ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning AT fanuellampiao ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning AT reubenmaghembe ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning AT hedmonokella ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning AT ankeweisheit ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning AT casimutolo ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning AT patrickeogwang ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning AT duncancsesaazi ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning |
_version_ |
1721222780193603584 |
spelling |
doaj-9dd3b57134704c0a8c26e005f95d50fd2021-08-04T04:20:22ZengElsevierScientific African2468-22762021-07-0112e00824Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designingAndrew G. Mtewa0Jonathan T. Bvunzawabaya1Kennedy J. Ngwira2Fanuel Lampiao3Reuben Maghembe4Hedmon Okella5Anke weisheit6Casim U. Tolo7Patrick E. Ogwang8Duncan C. Sesaazi9Chemistry Section, Department of Applied Studies, Institute of Technology, Malawi University of Science and Technology, Malawi; Pharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, Uganda; Corresponding author at: Chemistry Section, Department of Applied Sciences, Institute of Technology, Malawi University of Science and Technology, Malawi.Department of Biomedical Sciences, Kamuzu University of Health Sciences, Blantyre, Malawi; Africa Centre of Excellence in Public Health and Herbal Medicine (ACEPHEM), Kamuzu University of Health Sciences, MalawiSchool of Chemistry, Institute of Molecular Science, University of Witwatersrand, South AfricaDepartment of Biomedical Sciences, Kamuzu University of Health Sciences, Blantyre, Malawi; Africa Centre of Excellence in Public Health and Herbal Medicine (ACEPHEM), Kamuzu University of Health Sciences, MalawiBiotechnology Section, Centre for Chemistry and Chemical Engineering, Lund University, Lund, Sweden; Marian University College, Department of Biological and Marine Sciences, Bagamoyo, TanzaniaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaMycobacterium tuberculosis remains one of the world's contributors to mortality. With the emergence of SARS-CoV-2 coinfections, patients with TB are predisposed to being more heavily weighed down by COVID-19 disease and its opportunistic coinfections. The severity of the disease coupled with drug resistance on the currently used drugs warrants for the search for alternative remedies from synthetic agents, semisynthetics and natural products that include plants. Africa is rich in plant diversity with a promise as sources of drug agents, one of which is Eichhornia crassipes. This work aimed at isolating a fatty acid and dock it to β-ketoacyl-ACP synthase for possible anti-TB drug development prospects using computational tools. (9z,12z)-Octadeca-9,12-dienoic acid was isolated from Eichhornia crassipes for the first time using chromatographic techniques and identified using 1D and 2D NMR spectroscopic methods (1H NMR, COSY, HSQC, HMBC and 13C NMR). The compound was then docked to β-ketoacyl-ACP synthase (KasA), an essential member of the b-ketoacyl synthases encoded in the M. tuberculosis genome in comparison with its co-crystallized ligand JSF-3285, also for the first time. (9z,12z)-Octadeca-9,12-dienoic acid interacted with only phenylalanine239 and proline201 while JSF-3285 interacted with proline201, glutamine120, alanine119, leucine116, glutamine199, histadine345, phenylalanine239, glycine240 and glycine200. (9z,12z)-Octadeca-9,12-dienoic acid had a ligand efficiency of 0.24, compared to the co-crystallized ligand's 0.36. The compound was too flexible and elongated with -4.72 KCalmol−1 binding energy. Despite some unfavourable physico-chemical properties, the compound still provides reliable interactions that only require logical structural modifications by the addition of polar regions amongst others to increase interactions and ligand efficiency, which can consequently stand to be a better potential drug lead. For the first time, plant-based (9z,12z)-Octadeca-9,12-dienoic acid isolated from Eichhornia crassipes was shown to interact fairly well with β-ketoacyl-ACP synthase and proved to be a potential starting material from which anti-tubercular drugs can be designed.http://www.sciencedirect.com/science/article/pii/S2468227621001289Ligand efficiencyβ-ketoacyl-ACP synthaseDrug designKasA inhibitorDrug-protein interactionsM. tuberculosis |